malignant (cancerous) tumor of the liver that usually occurs in the first 3 years of life. In early stages of the condition, there may be no concerning signs or symptoms. As the tumor gets larger, affected children may experience a painful, abdominal lump; swelling of the abdomen; unexplained weight loss; loss of appetite; and/or nausea and vomiting. The exact underlying cause of hepatoblastoma is poorly understood. Risk factors for the tumor include prematurity with a very low birth weight, early exposure to hepatitis B infection, biliary atresia, and several different genetic conditions (i.e. Beckwith-Wiedemann syndrome, familial adenomatous polyposis, Aicardi syndrome, Glycogen storage disease, and Simpson-Golabi-Behmel syndrome). Treatment varies based on the severity of the condition but may include a combination of surgery, watchful waiting, chemotherapy, and/or radiation therapy.Hepatoblastoma is a rare
Last updated: 1/20/2016
- Jennifer Reikes Willert, MD. Pediatric Hepatoblastoma. Medscape Reference. November 2014; http://emedicine.medscape.com/article/986802-overview.
- Childhood Liver Cancer Treatment (PDQ®). National Cancer Institute. December 2015; http://www.cancer.gov/types/liver/patient/child-liver-treatment-pdq#section/_1.
- Devi LP1, Kumar R, Handique A, Kumar M. Hepatoblastoma--a rare liver tumor with review of literature. J Gastrointest Cancer. December 2014; 45 Suppl 1:261-264.
- The National Cancer Institute provides the most current information on cancer for patients, health professionals, and the general public.
- Medscape Reference provides information on this topic. You may need to register to view the medical textbook, but registration is free.
- Online Mendelian Inheritance in Man (OMIM) is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.
- Orphanet is a European reference portal for information on rare diseases and orphan drugs. Access to this database is free of charge.